Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion type Assertion NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_head.
- NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_provenance.
- NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion evidence source_evidence_literature NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_provenance.
- NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion SIO_000772 17192482 NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_provenance.
- NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion wasDerivedFrom befree-20150227 NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_provenance.
- NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion wasGeneratedBy ECO_0000203 NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_provenance.